Peripheral nerve hyperexcitability: A clinical and immunologic study of 38 patients

Neurology

Volumn 76, Issue 2, 2011, Pages 172-178

  Rubio Agusti, I ^a   Perez Miralles, F ^a   Sevilla, T ^a,b   Muelas, N ^a,b   Chumillas, M J ^a   Mayordomo, F ^b   Azorin, I ^b   Carmona, E ^c   Moscardo, F ^c   Palau, J ^a   Jacobson, L ^d   Vincent, A ^d   Vilchez, J J ^a   Bataller, L ^a,b  

^a Laboratory of Experimental Neurology   (United States)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRAIN ELECTROPHYSIOLOGY; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOLOGY; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE TWITCH; MYASTHENIA GRAVIS; MYOSITIS; NEOPLASM; NERVOUS TISSUE; NEUROPATHY; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NERVE; PERIPHERAL NERVE HYPEREXCITABILITY; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; RADIOIMMUNOPRECIPITATION; RAT; THYMOMA; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOPSY; ELECTROPHYSIOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; PARANEOPLASTIC POLYNEUROPATHY; PERIPHERAL NERVOUS SYSTEM DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED; RADIOIMMUNOPRECIPITATION ASSAY; RISK FACTORS; THYMOMA; THYROID NEOPLASMS; YOUNG ADULT;

EID: 78751633755     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182061b1e     Document Type: Article

References (25)

1. Tahmoush AJ, Alonso RJ, Tahmoush GP, Heiman-Patterson TD. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991; 41:1021-1024.
2. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-1895.
3. Gutmann L, Libell D, Gutmann L. When is myokymia neuromyotonia? Muscle Nerve 2001;24:151-153.
4. Eunson LH, Rea R, Zuberi SM, et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000;48:647-656.
5. Newsom-Davis J, Buckley C, Clover L, et al. Autoimmune disorders of neuronal potassium channels. Ann NY Acad Sci 2003;998:202-210.
6. Gutmann L, Gutmann L. Myokymia and neuromyotonia. J Neurol 2004;251:138-142.
7. Maddison P. Neuromyotonia. Clin Neurophysiol 2006; 117:2118-2127.
8. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.
9. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): report of five cases and literature review. Brain 1993;116:453-469.
10. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702-707.
11. Vincent A. Antibodies to contactin-associated protein 2 (CASPR2) in thymoma and Morvan's syndrome. Ann Neurol 2009;66(suppl 13):S3. Abstract.
12. Donofrio PD, Albers JW. AAEM minimonograph 34: polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve 1990;13:889-903.
13. Gutmann L, Pawar GV. An approach to electrodiagnosis of peripheral neuropathies. Semin Neurol 2005;25:160-167.
14. Azorin I, Portoles M, Marin P, et al. Prenatal ethanol exposure alters the cytoskeleton and induces glycoprotein microheterogeneity in rat newborn hepatocytes. Alcohol Alcohol 2004;39:203-212.
15. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140.
16. Worrall BB, Rowland LP, Chin SS, Mastrianni JA. Amyotrophy in prion diseases. Arch Neurol 2000;57:33-38.
17. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008;65:1341-1346.
18. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
19. Irani SR, Waters P, Kleopa KA, Lang B, Vincent A. Antibodies to components of the voltage-gated potassium channel-associated complex: LGI1 and Caspr2 as antigenic targets in limbic encephalitis, Morvan's and neuromyoto-nia. Neurology 2010;75:379-381. Abstract.
20. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins Leucine-rich glioma inactivated 1 protein and Contactin-associated protein 2 in limbic encephalitis, Morvan's syndrome and acquired neu-romyotonia. Brain 2010;133:2734-2748.
21. Oh SJ, Alapati A, Claussen GC, Vernino S. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies. Muscle Nerve 2003;27:757-760.
22. Maddison P, Mills KR, Newsom-Davis J. Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability. Muscle Nerve 2006;33:801-808.
23. Arimura K, Arimura Y, Ng A, et al. The origin of spontaneous discharges in acquired neuromyotonia: a Macro EMG study. Clin Neurophysiol 2005;116:1835-1839.
24. Mygland A, Vincent A, Newsom-Davis J, et al. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol 2000;57:527-531.
25. Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 2005;62:442-446.